Given that we previously demonstrated that Survivin is overexpressed in PAH-PASMCs contributing to the development of PAH7, 51, HDAC6 inhibition may also contribute to improve PAH by reducing the cytoplasmic pool of Survivin leading to increased sensitivity to apoptosis. The gene discussed is HDAC6; the disease is pulmonary arterial hypertension.